Tim H.
- Country
- Germany
- Department
- Klinik fuer Neurologie
Research Overview
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Iptacopan in Patients with Generalized Myasthenia Gravis
- Evaluation of High-Dose Nusinersen in Spinal Muscular Atrophy Patients Previously Treated with Risdiplam: A Phase 3b Clinical Trial
- Efficacy and Safety Evaluation of Inebilizumab in Adults with Acetylcholine Receptor or Muscle-Specific Kinase Antibody-Positive Myasthenia Gravis
Data & Insights
Has run more than one trial at 38 of 116 partner sites.
Specializations
Neuromuscular Disorders
This investigator specializes in treating muscular dystrophies, including Limb Girdle Muscular Dystrophy and Myotonic Dystrophy Type 1. Their research extends to innovative therapeutic approaches for these conditions.
- Limb Girdle Muscular Dystrophy 2I/R9
- Myotonic Dystrophy Management
Neurological Conditions
The investigator focuses on treating complex neurological disorders including Spinocerebellar Ataxia and Huntington's Disease. Their work encompasses innovative therapeutic approaches for these progressive conditions.
- Spinocerebellar Ataxia Types 1 and 3
- Huntington's Disease Treatment
- Spinal Muscular Atrophy
Autoimmune Disorders
The investigator specializes in treating autoimmune neuromuscular conditions, particularly Myasthenia Gravis and Dermatomyositis. Their expertise includes both traditional and emerging therapeutic approaches.
- Generalized Myasthenia Gravis
- Dermatomyositis Treatment
- Autoimmune Neuromuscular Disorders
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.